In contrast, GSK503 inhibits Ezh2 much more strongly than it inhibits other histone methyltransferases, yet still effectively blocks bm12-induced lupus-like cGVHD in mice (Fig. 6) without obvious adverse effects. This evidence concerns the gene PRDM9 and systemic lupus erythematosus.